Understand the source comparison
Glow Stack Help Wrinkles: Formulation Comparison
GHK-Cu (Copper Peptide) MMP inhibition + collagen gene upregulation 340 Da Topical, liposomal, injectable Strong. Multiple RCTs showing 18–31% collagen increase at 12 weeks Best evidence for structural collagen synthesis; requires consistent 90-day protocol Ma
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GHK-Cu (Copper Peptide)
- MMP inhibition + collagen gene upregulation
- 340 Da
- Topical, liposomal, injectable
- Strong. Multiple RCTs showing 18–31% collagen increase at 12 weeks
- Best evidence for structural collagen synthesis; requires consistent 90-day protocol
- Matrixyl (Palmitoyl Pentapeptide-4)
- Mimics collagen fragment signals to stimulate fibroblast activity
- 578 Da
- Topical, requires penetration enhancers
- Moderate. Controlled trials show 19–23% wrinkle depth reduction at 12 weeks
- Proven efficacy but penetration-dependent; works best with microneedling or liposomal delivery
- Argireline (Acetyl Hexapeptide-8)
- Inhibits SNARE complex formation, reducing muscle contraction
- 888 Da
- Topical (limited penetration)
- Weak. Mostly surface effects; minimal histological evidence of dermal changes
- Functions more as topical muscle relaxant than collagen modulator; effects temporary and surface-level
- BPC-157 (Body Protection Compound)
- Promotes angiogenesis and tissue repair via growth factor pathways
- 1419 Da
- Injectable only (too large for transdermal)
- Emerging. Animal studies strong, human dermatological trials limited
- Promising mechanism but requires systemic administration; not viable as topical for wrinkles